Cellyan Biotechnology Co., Ltd

For the period ended Mar 31, 2026. Filed Aug 7, 2026.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2026 · Filed Aug 7, 2026

HKPD$1.45+6.6%Stored close · as of Nov 6, 2026

Contents

8.B. Significant Changes

No significant change has occurred since the date of our consolidated financial statements filed as part of this Annual Report.

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.